The article is devoted to the treatment of diabetic neuropathy. The described scheme of application of preparations of alpha-lipoic (thioctic) acid. Recently in Europe and the United States conducted a series of clinical studies that have shown that the minimal period of the reaction to therapy drugs alpha lipoic acid is 21-28 days, during this time decreases symptoms of diabetic polyneuropathy. Optimal time course of treatment is the period of 3 months, which helps to eliminate metabolic injury, subject to the mandatory re courses with a break in 1-3-6 months. The total duration of therapy of neuropathy alpha lipoic acid should be at least one year
Diabetic neuropathy represents late diabetes complications, and diabetes duration and long-term hype...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Objective. We performed a systematic review of the literature to evaluate the effects of alpha lipoi...
Diabetic neuropathy is the most common complication of diabetes mellitus. Among the large number of ...
This article tells about the treatment of diabetic polyneuropathy - the most common neurological com...
Both oral and intravenous administration of alpha-lipoic acid (ALA) has been investigated as add-on ...
The article highlights the questions of pathogenesis and treatment of diabetic neuropathy — one of t...
-Lipoic acid in symptomatic diabetic polyneuropathy: A meta-analysis Address for correspondence
The article details the pathogenesis of diabetic polyneuropathy (DPN) and tells about the stages and...
The increase in the number and life expectancy of patients with diabetes mellitus (DM) worldwide det...
Early diagnosis and timely rational therapy of DP allow to prevent disability, increase duration and...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
The most common form of peripheral nervous system damage in diabetes mellitus is distal symmetric se...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Diabetic neuropathy represents late diabetes complications, and diabetes duration and long-term hype...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Objective. We performed a systematic review of the literature to evaluate the effects of alpha lipoi...
Diabetic neuropathy is the most common complication of diabetes mellitus. Among the large number of ...
This article tells about the treatment of diabetic polyneuropathy - the most common neurological com...
Both oral and intravenous administration of alpha-lipoic acid (ALA) has been investigated as add-on ...
The article highlights the questions of pathogenesis and treatment of diabetic neuropathy — one of t...
-Lipoic acid in symptomatic diabetic polyneuropathy: A meta-analysis Address for correspondence
The article details the pathogenesis of diabetic polyneuropathy (DPN) and tells about the stages and...
The increase in the number and life expectancy of patients with diabetes mellitus (DM) worldwide det...
Early diagnosis and timely rational therapy of DP allow to prevent disability, increase duration and...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
The most common form of peripheral nervous system damage in diabetes mellitus is distal symmetric se...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Diabetic neuropathy represents late diabetes complications, and diabetes duration and long-term hype...
Background: Neuropathic pain is difficult to treat. We identified those studies in the literature in...
Objective. We performed a systematic review of the literature to evaluate the effects of alpha lipoi...